Alvotech (ALVO) stock is in focus as the company partners with Advanz Pharma to market three additional biosimilars across ...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to ...

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic ...

Alvo Minerals Limited has announced an update to a previous announcement regarding a proposed issue of securities. The company will remain in voluntary suspension until the comple ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...

Alvotech (NASDAQ: ALVO, the "Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announces the outcome of the ...

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Good day, and thank you for standing by. Welcome to the Alvotech Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there ...

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Alvotech (NASDAQ:ALVO) stands against the other stocks ...

In this article, we are going to take a look at where Alvotech (NASDAQ:ALVO) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday, May 7 ...

Selarsdi is FDA-approved in all Stelara-equivalent forms for psoriasis, arthritis, Crohn's, and colitis. Three biosimilar BLAs from Teva-Alvotech are under FDA review, with approvals expected in ...